The following drugs will decrease rifampicin effect

#

enzyme

inducers

the follwing drugs will Increase rifampicin effect

#

enzyme

Inhibitors

level

The following drugs will decreased effect by rifampicin effect

#	enzyme	drug
1	2C19	amitriptyline
2	2C19	atomoxetine
3	2C19	brivaracetam
4	2C19	carisoprodol
5	2C19	celecoxib
6	2C19	chloramphenicol
7	2C19	citalopram
8	2C19	clobazam
9	2C19	clomipramine
10	2C19	clopidogrel
11	2C19	cyclophosphamide
12	2C19	diazepam
13	2C19	doxepin
14	2C19	escitalopram
15	2C19	esomeprazole
16	2C19	flibanserin
17	2C19	hexobarbital
18	2C19	imipramine
19	2C19	indomethacin
20	2C19	labetalol
21	2C19	lansoprazole
22	2C19	mavacamten
23	2C19	moclobemide
24	2C19	nelfinavir
25	2C19	nilutamide
26	2C19	omeprazole
27	2C19	ospemifene
28	2C19	pantoprazole
29	2C19	phenobarbitone
30	2C19	phenytoin
31	2C19	pomalidomide
32	2C19	primidone
33	2C19	progesterone
34	2C19	proguanil
35	2C19	propranolol
36	2C19	r-mephobarbital
37	2C19	r-warfarin
38	2C19	s-mephenytoin
39	2C19	suvorexant
40	2C19	teniposide
41	2C19	tofacitinib
42	2C19	venlafaxine
43	2C19	vilazodone
44	2C19	voriconazole

will decrease rifampicin effect

#

enzyme

inducers

rifampicin will not affect

Strong inhibitor is one that causes a ≥ 5-fold decrease in the plasma AUC values or more than 80% decrease in clearance.
Moderate inhibitor is one that causes a 2 fold to < 5-fold decrease in the plasma AUC values or 50-80% decrease in clearance.
Weak inhibitor is one that causes a ≥ 1.25-fold but < 2-fold decrease in the plasma AUC values or 20-50% decrease in clearance.
In-Vitro Only In-Vitro Only Inhibitor strength.
under review Inhibitor strength level is under review.